Upper Respiratory Tract Infection
📧 Sign up to get email alerts when something new happens for Upper Respiratory Tract Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Trial of Post-Dated Delayed Antibiotic Prescriptions [NA]
A completed clinical trial evaluating post-dated delayed antibiotic prescriptions for acute upper respiratory tract infections; results post…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults [Phase 3]
Phase 3 trial assessing safety and efficacy of Ergoferon in liquid form for acute upper respiratory tract infections completed with posted r…
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Challenge Infection of Healthy Adult Volunteers With RSV A2 [Phase 1]
Phase 1 clinical trial update involving deliberate infection of healthy adults with RSV A2; study completed with results posted.
-
FDA approval · 2020-09-30FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE — Original Application (BIONPHARMA INC.)
FDA approved Bionpharma's original ANDA for a three-drug cough/cold product containing brompheniramine maleate, pseudoephedrine hydrochlorid…
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life [Phase 4]
A Phase 4 clinical trial investigated using pneumococcal vaccines in combination to maximize protection against ear and lung infections in t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013) [Phase 2]
A Phase 2 clinical trial of gefapixant (MK-7264) for acute cough due to induced viral URTI was terminated with results posted in 2019.
-
CLINICAL_TRIALS research · 2019-02-08Clinical Trial Update: Clinical Trials to Assess the Efficacy and Safety of HLIM [Phase 3]
A Phase 3 clinical trial update for HLIM evaluating efficacy and safety in acute upper respiratory tract infection and acute bronchitis; the…
-
FDA approval · 2018-11-01FDA Approved: MUCUS RELIEF DM — Original Application (Dolgencorp, Inc. (DOLLAR GENERAL & REXALL))
FDA approved the original application for MUCUS RELIEF DM, a combination cough suppressant and expectorant (guaifenesin and dextromethorphan…
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children [Phase 3]
Phase 3 trial assessing safety and efficacy of Ergoferon in liquid dosage form for acute upper respiratory tract infections in children has …
-
FDA approval · 2018-06-08FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Oseltamivir Randomised Controlled Efficacy Trial [Phase 3]
Phase 3 randomized controlled trial evaluating the efficacy of oseltamivir for influenza and related respiratory infections; the study has c…
-
CLINICAL_TRIALS withdrawal · 2018-05-07Clinical Trial Update: A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection [Phase 2]
The Phase 2 trial of vapendavir for rhinovirus infection in hematopoietic stem cell transplant patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections [NA]
A completed UCLA-sponsored clinical trial evaluated a behavioral economics intervention aimed at reducing inappropriate antibiotic prescribi…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Birth Cohort Study for Respiratory Infections
A Nestlé-sponsored birth cohort trial assessing upper respiratory tract infections has completed.
-
CLINICAL_TRIALS research · 2018-03-12Clinical Trial Update: A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection（a Chinese Medicine Injection）Used in Hospitals in China
A registry study in China tracks 100,000 pediatric cases treated with Reduning Injection for upper respiratory tract infection and acute tra…
-
FDA approval · 2018-03-05FDA Approved: MUCUS DM — Original Application (HyVee Inc)
FDA approved HyVee Inc's MUCUS DM as an original-application generic product containing dextromethorphan hydrobromide and guaifenesin for te…
-
FDA approval · 2017-07-13FDA Approved: MUCINEX DM MAXIMUM STRENGTH — Supplemental Application (RB Health (US) LLC)
FDA approved a supplemental application for Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide) by RB Health (US) LL…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production [Phase 1]
A Phase 1 safety study comparing two PrEP-001 nasal powder formulations to assess effects on nasal mucosa and serum cytokine responses in pa…
-
CLINICAL_TRIALS research · 2017-06-01Clinical Trial Update: Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data
This ClinicalTrials.gov entry reports an ongoing study using acoustic analytics for smart telehealth screening to detect upper respiratory t…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Maternal Vitamin D for Acute Respiratory Infections in Infancy [Phase 3]
Phase 3 trial evaluating maternal vitamin D supplementation to prevent acute respiratory infections in infancy; the study has completed.
-
CLINICAL_TRIALS research · 2017-03-22Clinical Trial Update: Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life [Phase 3]
Phase 3 clinical trial assessing whether vitamin D supplementation in the first year of life can prevent acute bronchitis and other respirat…
-
FDA approval · 2017-03-17FDA Approved: MUCUS RELIEF DM MAXIMUM STRENGTH — Original Application (Better Living Brands LLC)
The FDA approved the original ANDA for MUCUS RELIEF DM MAXIMUM STRENGTH, a combination product of guaifenesin and dextromethorphan hydrobrom…
-
CLINICAL_TRIALS research · 2017-01-12Clinical Trial Update: Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2
A prospective clinical evaluation of the FilmArray Respiratory Panel 2, conducted by BioFire Diagnostics, is completed for upper respiratory…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation [NA]
A Danone-sponsored clinical trial evaluating a fermented milk product (probiotic beverage) for preventing common infections in adults under …
-
FDA approval · 2016-08-25FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)
FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) from Mainpointe Pharmaceuticals. The ap…